A novel PRMT5 inhibitor with potent in vitro and in vivo activity in preclinical lung cancer models

被引：15
|
作者：
Brehmer, Dirk
Wu, Tongfei
Mannens, Geert
Beke, Lijs
Vinken, Petra
Gaffney, Dana
Sun, Weimei
Pande, Vineet
Thuring, Jan-Willem
Millar, Hillary
Poggesi, Italo
Somers, Ivan
Boeckx, An
Parade, Marc
van Heerde, Erika
Nys, Thomas
Yanovich, Carol
Herkert, Barbara
Verhulst, Tinne
Du Jardin, Marc
Meerpoel, Lieven
Moy, Christopher
Diels, Gaston
Viellevoye, Marcel
Schepens, Wim
Poncelet, Alain
Linders, Joannes T.
Lawson, Edward C.
Edwards, James P.
Chetty, Dushen
Laquerre, Sylvie
Lorenzi, Matthew V.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-DDT02-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDT02-04
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
    Shuangjie Liu
    Zhuonan Liu
    Chiyuan Piao
    Zhe Zhang
    Chuize Kong
    Lei Yin
    Xi Liu
    Journal of Experimental & Clinical Cancer Research, 41
  • [12] Discovery of novel potent and selective inhibitors of PRMT5 with anti-tumor activity in hepatocellular carcinoma and lung pre-clinical models
    Gonzalvez, Francois
    Vandyck, Koen
    Debing, Yannick
    Gupta, Kusum
    Misner, Dinah
    Zhang, Qingling
    Liu, Jyanwei
    Stoycheva, Antitsa
    Stevens, Sarah
    Symons, Julian
    Beigelman, Leonid
    Raboisson, Pierre
    Deval, Jerome
    CANCER RESEARCH, 2020, 80 (16)
  • [13] PRMT5, a Novel Epigenetic Target in Lung Cancers
    Otterson, G. A.
    Wu, X.
    Welliver, M.
    Sharma, S.
    Shilo, K.
    Hitchcock, C.
    Li, C.
    Baiocchi, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 171 - 171
  • [14] DISCOVERY AND PHARMACOLOGICAL CHARACTERIZATION OF SKL27969, A NOVEL BRAINPENETRATING PRMT5 INHIBITOR WITH STRONG ANTITUMOR ACTIVITY, IN GLIOBLASTOMA AND BRAIN METASTASIS PRECLINICAL MODELS
    Moon, Mijin
    Shin, Yongje
    Lee, Ho Yeon
    Hong, Beomjin
    Kim, Jinhee
    Lee, Jun
    Laramy, Janice K.
    Vashi, Vijaykumar
    Park, Sook-Kyung
    NEURO-ONCOLOGY, 2022, 24 : 233 - 234
  • [15] Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
    Smith, James M.
    Barlaam, Bernard
    Beattie, David
    Bradshaw, Lauren
    Chan, Ho Man
    Chiarparin, Elisabetta
    Collingwood, Olga
    Cooke, Sophie L.
    Cronin, Anna
    Cumming, Iain
    Dean, Emma
    Debreczeni, Judit E.
    del Barco Barrantes, Ivan
    Diene, Coura
    Gianni, Davide
    Guerot, Carine
    Guo, Xiaoxiao
    Guven, Sinem
    Hayhow, Thomas G.
    Hong, Ted
    Kemmitt, Paul D.
    Lamont, Gillian M.
    Lamont, Scott
    Lynch, James T.
    McWilliams, Lisa
    Moore, Shaun
    Raubo, Piotr
    Robb, Graeme R.
    Robinson, James
    Scott, James S.
    Srinivasan, Bharath
    Steward, Oliver
    Stubbs, Christopher J.
    Syson, Karl
    Tan, Lixiang
    Turner, Oliver
    Underwood, Elizabeth
    Urosevic, Jelena
    Vazquez-Chantada, Mercedes
    Whittaker, Amy L.
    Wilson, David M.
    Winter-Holt, Jon J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13604 - 13638
  • [16] PRMT5, A NOVEL EPIGENETIC TARGET IN LUNG CANCERS
    Otterson, Gregory A.
    Wu, Xin
    Welliver, Meng
    Sharma, Smita
    Shilo, Konstantin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S757 - S758
  • [17] PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells
    Bajbouj, Khuloud
    Ramakrishnan, Rakhee K.
    Saber-Ayad, Maha
    Omar, Hany A.
    Saheb Sharif-Askari, Narjes
    Shafarin, Jasmin
    Elmoselhi, Adel B.
    Ihmaid, Ahmed
    AlHaj Ali, Suhib
    Alalool, Abdulla
    Abdullah, Reem
    Hamid, Qutayba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [18] Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
    Brehmer, Dirk
    Beke, Lijs
    Wu, Tongfei
    Millar, Hillary J.
    Moy, Christopher
    Sun, Weimei
    Mannens, Geert
    Pande, Vineet
    Boeckx, An
    van Heerde, Erika
    Nys, Thomas
    Gustin, Emmanuel M.
    Verbist, Bie
    Zhou, Longen
    Fan, Yue
    Bhargava, Vipul
    Safabakhsh, Pegah
    Vinken, Petra
    Verhulst, Tinne
    Gilbert, Angelique
    Rai, Sumit
    Graubert, Timothy A.
    Pastore, Friederike
    Fiore, Danilo
    Gu, Junchen
    Johnson, Amy
    Philippar, Ulrike
    Morschhauser, Barbara
    Walker, David
    De Lange, Desiree
    Keersmaekers, Vikki
    Viellevoye, Marcel
    Diels, Gaston
    Schepens, Wim
    Thuring, Jan Willem
    Meerpoel, Lieven
    Packman, Kathryn
    Lorenzi, Matthew V.
    Laquerre, Sylvie
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2317 - 2328
  • [19] The novel Hsp90 inhibitor STA-9090 has potent anticancer activity in in vitro and in vivo models of lung cancer
    Shimamura, Takeshi
    Borgman, Christa
    Chen, Liang
    Li, Danan
    Foley, Kevin
    Sang, Jim
    Meyerson, Matthew
    Ying, Weiwen
    Barsoum, James
    Wong, Kwok-Kin
    Shapiro, Geoffrey
    CANCER RESEARCH, 2009, 69
  • [20] Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer
    Brobbey, Charles
    Yin, Shasha
    Liu, Liu
    Ball, Lauren E.
    Howe, Philip H.
    Delaney, Joe R.
    Gan, Wenjian
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345